New surgical method relieves heartburn symptoms

June 25, 2012
New surgical method relieves heartburn symptoms

One in three Austrians suffer from heartburn. If the symptoms become chronic, it can lead to serious conditions such as oesophageal cancer. A new surgical method, in which a magnetic ring is positioned almost like a “valve” at the distal end of the oesophagus, now allows the reflux of gastric acid to be prevented. This surgical method has been carried out successfully for the first time in the University Department of Surgery at the MedUni Vienna at the Vienna General Hospital by Sebastian Schoppmann and Martin Riegler.

The new procedure is called the LINX Management System and comprises a magnetic, mobile string of beads that is positioned around the outlet of the oesophagus and replaces the natural valve mechanism that no longer functions properly in patients with . “The system prevents the reflux of gastric acid into the oesophagus, thereby stopping the symptoms associated with the condition such as heartburn or acid reflux,” says Schoppmann.

“The implantation of the Reflux Management System is minimally invasive, is carried out via four small incisions and a laparoscopy and takes around half an hour,” explains Schoppmann. “First, the circumference of the oesophagus is measured so that the ring can be adapted to fit perfectly.”

The patient can swallow again perfectly normally immediately after the operation and is able to eat normally again the very next day. “This treatment represents an innovative therapeutic option for patients that will permanently relieve them of unpleasant symptoms in a relatively straightforward manner. Their quality of life is improved considerably,” says Riegler, Head of Functional Diagnostics at the University Department of Surgery.

Explore further: First US case since FDA-approval, new magnetic device for heartburn

Related Stories

First US case since FDA-approval, new magnetic device for heartburn

April 11, 2012
On Monday, April 9, 2012, Santiago Horgan, MD, chief of minimally invasive surgery at UC San Diego Health System implanted the new FDA-approved LINX device in a 29-year old patient suffering from gastroesophageal reflux disease ...

New incision-free surgery helps tame chronic acid reflux

December 12, 2011
(Medical Xpress) -- Adam Vasser would wake up at night choking on partially digested food and liquid. Stomach acid burned the delicate tissue of his throat. “I’d sleep really badly,” he said.

Prevalence of acid reflux has increased by half over the past decade

January 5, 2012
The prevalence of acid reflux experienced at least once a week has increased by almost 50%  over the past decade, NTNU researchers report in a long term study of almost 80,000 people published online in Gut.

URMC offers new implantable heartburn 'ring'

May 31, 2012
The University of Rochester Medical Center (URMC) is one of just 13 U.S. surgery sites chosen to offer the LINX Reflux Management System, a new implantable magnetic “ring” that promises relief to the estimated 25 ...

Recommended for you

Researchers developing new tool to distinguish between viral, bacterial infections

July 28, 2017
Antibiotics are lifesaving drugs, but overuse is leading to one of the world's most pressing health threats: antibiotic resistance. Researchers at the University of Rochester Medical Center are developing a tool to help physicians ...

Finish your antibiotics course? Maybe not, experts say

July 27, 2017
British disease experts on Thursday suggested doing away with the "incorrect" advice to always finish a course of antibiotics, saying the approach was fuelling the spread of drug resistance.

Co-infection with two common gut pathogens worsens malnutrition in mice

July 27, 2017
Two gut pathogens commonly found in malnourished children combine to worsen malnutrition and impair growth in laboratory mice, according to new research published in PLOS Pathogens.

Phase 3 trial confirms superiority of tocilizumab to steroids for giant cell arteritis

July 26, 2017
A phase 3 clinical trial has confirmed that regular treatment with tocilizumab, an inhibitor of interleukin-6, successfully reduced both symptoms of and the need for high-dose steroid treatment for giant cell arteritis, the ...

A large-scale 'germ trap' solution for hospitals

July 26, 2017
When an infectious airborne illness strikes, some hospitals use negative pressure rooms to isolate and treat patients. These rooms use ventilation controls to keep germ-filled air contained rather than letting it circulate ...

Researchers report new system to study chronic hepatitis B

July 25, 2017
Scientists from Princeton University's Department of Molecular Biology have successfully tested a cell-culture system that will allow researchers to perform laboratory-based studies of long-term hepatitis B virus (HBV) infections. ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.